¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oxygen cycle"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • oogenetic cycle
    ³­¼ÒÁÖ±â
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovulation cycle
    ¹è¶õÁÖ±â
  • photochemical cycle
    ±¤È­ÇÐȸ·Î
  • pulse cycle
    ¸Æ¹ÚÁÖ±â
  • pain-spasm-pain cycle
    ÅëÁõ¿¬ÃàÅëÁõÁÖ±â
  • reproduction cycle
    »ý½ÄÁÖ±â
  • reversible cycle
    °¡¿ªÈ¸·Î
  • sporogenous cycle
    Ȧ¾¾Çü¼º±â, Æ÷ÀÚÇü¼º±â
  • sylvatic life cycle
    ¾ß»ý»ýȰÁÖ±â
  • sexual cycle
    ¼ºÁÖ±â
  • urea cycle
    ¿ä¼Òȸ·Î
  • arterial oxygen saturation
    µ¿¸ÆÇ÷»ê¼ÒÆ÷È­µµ
  • arterial oxygen tension
    µ¿¸ÆÇ÷»ê¼ÒºÐ¾Ð
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovulation cycle
    ¹è¶õÁÖ±â
  • photochemical cycle
    ±¤È­ÇÐȸ·Î
  • pulse cycle
    ¸Æ¹ÚÁÖ±â
  • reproduction cycle
    »ý½ÄÁÖ±â
  • reversible cycle
    °¡¿ªÈ¸·Î
  • sexual cycle
    ¼ºÁÖ±â
  • sporogenous cycle
    Ȧ¾¾Çü¼º±â, Æ÷ÀÚÇü¼º±â
  • sylvatic life cycle
    ¾ß»ý»ýȰÁÖ±â
  • tricarboxylic acid cycle
    »ïÄ«¸£º¹½Ç»êȸ·Î
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
  • alveolar oxygen pressure
    ÆóÆ÷»ê¼Ò¾Ð
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£»ê¼ÒºÐ¾ÐÂ÷
  • arterial oxygen saturation
    µ¿¸ÆÇ÷»ê¼ÒÆ÷È­µµ
  • arterial oxygen tension
    µ¿¸ÆÇ÷»ê¼ÒºÐ¾Ð
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷
  • arterial blood oxygen tension
    µ¿¸ÆÇ÷»ê¼Ò Àå·Â.
  • arterial oxygen content
    µ¿¸ÆÇ÷»ê¼ÒÇÔÀ¯·®
  • arterial oxygen saturation
    µ¿¸ÆÇ÷ »ê¼ÒÆ÷È­µµ
  • arterial oxygen tension
    µ¿¸ÆÇ÷»ê¼ÒºÐ¾Ð, µ¿¸ÆÇ÷»ê¼ÒÀå·Â
  • arterial oxygen tension
    µ¿¸ÆÇ÷ »ê¼ÒºÐ¾Ð
  • arterial-venous oxygen content difference
    µ¿¸Æ-Á¤¸Æ»ê¼Ò¿ëÀûÂ÷ÀÌ
  • arterial-venous oxygen difference
    µ¿¸Æ-Á¤¸Æ »ê¼ÒÂ÷ÀÌ
  • arteriovenous oxygen content difference
    µ¿Á¤¸ÆÇ÷ »ê¼ÒÇÔ·®Â÷
  • arteriovenous oxygen difference
    µ¿Á¤¸ÆÇ÷ »ê¼Ò±³Â÷(¡­úìß«áÈÎòó¬)
  • arteriovenous oxygen tension difference
    µ¿Á¤¸ÆÇ÷ »ê¼ÒºÐ¾ÐÂ÷
  • heavy oxygen
    Áß»ê¼Ò(ñìß«áÈ).
  • hyperbaric oxygen
    °í¾Ð»ê¼Ò
  • hyperbaric oxygen therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • ideal alveolar oxygen tension
    ÀÌ»ó(Àû)ÆóÆ÷ »ê¼ÒÀå·Â(ìµßÌîÜøËøàß«áÈíåæ³).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cycle, infection
    °¨¿°ÁÖ±â
  • cycle, life
    »ýȰ»ç, »ýȰÁÖ±â, »ýȰȯ
  • day-night cycle
    ¹ã³·ÁÖ±â(ñ¸Ñ¢)
  • developmental cycle
    ¹ßÀ°ÁÖ±â
  • diurnal cycle
    ÁÖ°£ÁÖ±â(ñ¸ÊàñÎÑ¢)
  • duty cycle
    µ¿ÀÛ ºñÀ²
  • endometrial cycle
    Àڱ󻸷ÁÖ±â.
  • endometrial cycle
    Àڱ󻸷ÁÖ±â(í­ÏàҮدñÎÑ¢).
  • epidemic cycle
    À¯Çà¼øÈ¯.
  • erythrocytic cycle
    ÀûÇ÷±¸¹ßÀ°È¯.±â»ýÀû³»¹ßÀ°È¯.
  • estrous cycle
    ¹ßÁ¤ÁÖ±â(¡­ñÎÑ¢).
  • estrous cycle
    ¹ßÁ¤ÁÖ±â
  • estrus cycle
    ¹ßÁ¤ÁÖ±â(¡­ñÎÑ¢).
  • female reproductive cycle
    ¿©¼º»ý½ÄÁÖ±â
  • gastric cycle
    À§ÁÖ±â(êÖñÎÑ¢).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • futile cycle
    ¹«ÀÍ È¸·Î(ÙíìÌüÞÖØ)
  • generation cycle
    ¼¼´ë ÁÖ±â(á¦ÓÛñÎÑ¢)
  • glucose-alanine cycle
    ±Û·çÄÚ½º-¾Ë¶ó´Ñ ȸ·Î(üÞÖØ)
  • ¥ã-glutamyl cycle
    ¥ã-±Û·çŸ¹Ð ȸ·Î(üÞÖØ)
  • glycine-allantoin cycle
    ±Û¶óÀ̽Å-¾Ë¶õÅäÀΠȸ·Î(üÞÖØ)
  • glycine-succinate cycle
    ±Û¶óÀ̽Å-¼®½Å»ê(ß«) ȸ·Î(üÞÖØ)
  • glycolic acid cycle
    ±Û¶óÀÌÄÝ»ê(ß«) ȸ·Î(üÞÖØ)
  • glyoxylate cycle
    ±Û¶óÀÌ¿Á½Ç»ê(ß«) ȸ·Î(üÞÖØ)
  • Krebs cycle
    Å©·¾½º ȸ·Î(üÞÖØ)
  • Krebs-Henseleit cycle
    Å©·¾½º-Ç¶óÀÌÆ® ȸ·Î(üÞÖØ)
  • Krebs-Kornberg cycle
    Å©·¾½º-Äܹö±× ȸ·Î(üÞÖØ)
  • life cycle
    "»ýȰ»ç(ßæüÀÞÈ),»ýȰÁÖ±â(ßæüÀñÎÑ¢)"
  • lysogenic cycle
    ¿ë¿øÁÖ±â(éÁê«ñÎÑ¢)
  • lytic cycle
    ¿ëÇØÁÖ±â(éÁú°ñÎÑ¢)
  • Meister cycle
    ¸¶À̽ºÅÍ È¸·Î(üÞÖØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CCS Canadian Cardiovascular Society; casualty clearing station; cell cycle specific; cholecystosonograph...
CDC calculated date of confinement; cancer diagnosis center; capillary diffusion capacity; cell division...
CL capillary lumen; cardiolipin; cell line; centralis lateralis; chemiluminescence; chest and left arm ...
CLP chymotrypsin-like protein; cleft lip with cleft palate; paced cycle length
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CY cycle
CE cycle ergometer
CE cycle ergometry
LD 12:12 light-dark cycle
L-D light-dark cycle
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chemical oxygen demand
    È­ÇÐÀû »ê¼Ò ¿ä±¸·®
  • hyperbaric oxygen chamber
    °í¾Ð »ê¼Ò½Ç
    °í¾ÐÀÇ »ê¼Ò¸¦ ÀÌ¿ëÇØ Àú»ê¼ÒÁõÀ» Ä¡·áÇϱâ À§ÇÑ ÀåÄ¡.
  • maximum oxygen consumption
    ÃÖ´ë »ê¼Ò ¼Ò¸ð·®
  • oxygen
    »ê¼Ò
    Æó¿¡¼­ Ç÷·ù·Î µé¾î°¡ »ýüÀÇ ¸ðµç ¼¼Æ÷¿¡ ¿î¹ÝµÇ´Â °¡½º.
  • oxygen affinity
    »ê¼Ò ģȭ¼º
  • oxygen balance
    »ê¼Ò ÆòÇü
  • oxygen carrier
    »ê¼Ò ¿î¹Ýü
  • oxygen coefficient
    »ê¼Ò °è¼ö
  • oxygen demand
    »ê¼Ò ÇÊ¿ä, »ê¼Ò Çʿ䷮, »ê¼Ò ¿ä±¸·®
  • oxygen deprivation
    »ê¼Ò °áÇÌ, »ê¼Ò ºÎÁ·
  • oxygen dissociation curve
    »ê¼Ò ÇØ¸® °î¼±
  • oxygen lack
    »ê¼Ò ºÎÁ·, »ê¼Ò °áÇÌ
  • oxygen poisoning
    »ê¼Ò Áßµ¶, »ê¼Ò Áßµ¶Áõ
    °í³óµµ »ê¼ÒÀÇ Àå±â°£ ÈíÀÔÀ¸·Î »ý±â´Â Æó ½ÇÁúÀÇ ½ÉÇÑ Àå¾Ö.
  • oxygen probe
    »ê¼Ò Žħ
  • oxygen reserve
    »ê¼Ò ¿¹ºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
oxygen deprivation theory of narcosis That narcotics inhibit oxidation, which causes the cell to be narcotised.
(05 Mar 2000)
oxygen derived free radicals An atom or atom group having an unpaired electron on an oxygen atom, typically derived from molecular oxygen. For example, one-electron reduction of O2 produces the superoxide radical, O2-; other examples include the hydroperoxyl radical (HOO-), the hydroxyl radical (HO-), and nitric oxide (NO-).
(05 Mar 2000)
oxygen effect Enhancement of radiosensitivity of cells in a high concentration of oxygen.
(05 Mar 2000)
oxygen electrode A sensitive method to detect oxygen consumption, involves a PTFE (Teflon) membrane.
(18 Nov 1997)
oxygen inhalation therapy Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask.
(12 Dec 1998)
oxygen isotopes Stable oxygen atoms that have the same atomic number as the element oxygen, but differ in atomic weight. O-17 and 18 are stable oxygen isotopes.
(12 Dec 1998)
oxygen poisoning A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation.
Synonym: oxygen poisoning.
(05 Mar 2000)
oxygen radical <chemistry> Any oxygen species that carries an unpaired electron (except free oxygen).
Examples are the hydroxyl radical and the superoxide anion. These radicals are very powerful oxidizing agents and cause structural damage to proteins and nucleic acids. They mediate the damaging effects of ionising radiation.
(18 Nov 1997)
oxygen radioisotopes Unstable isotopes of oxygen that decay or disintegrate emitting radiation. O atoms with atomic weights 13, 14, 15, 19, and 20 are radioactive oxygen isotopes.
(12 Dec 1998)
oxygen tent A transparent enclosure, suspended over the bed and enclosing the patient, used to supply a high concentration of oxygen.
(05 Mar 2000)
oxygen therapy Treatment in which an increased concentration of oxygen is made available for breathing, through a nasal catheter, tent, chamber, or mask.
(05 Mar 2000)
oxygen toxicity A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation.
Synonym: oxygen poisoning.
(05 Mar 2000)
oxygen utilization coefficient The extraction coefficient for oxygen in any given tissue.
(05 Mar 2000)
lactacid oxygen debt That part of an oxygen debt represented by the production of lactic acid by anaerobic glycolysis during exercise and, therefore, by the need to eliminate it by oxidative metabolism during recovery.
(05 Mar 2000)
fructosyl aminocaproate-oxygen oxidoreductase <enzyme> Catalyses conversion of amadori products to fructosamine; isolated from pseudomonas
Registry number: EC 1.5.3.-
Synonym: amadoriase, 1-deoxyfructosyl alkyl amino acid oxidase, fructosyl amino acid oxidase, faod enzyme
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á